About Us
About Noxopharm
CEO's Message
Management Team
Board of Directors
Scientific Advisors
Our Network
Pharmorage
ESG Commitment
Technology
Technology Platforms
Chroma™
Sofra™
mRNA Vaccines
Autoimmune Disease
Clinical Trials
Publications
Investor Centre
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
Contact Us
Contact Us
Partnering
Working at Noxopharm
ASX Announcements Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Share Price
Presentations & Interviews
Annual Reports
Financial Reports
ASX Announcements
Corporate Governance
Investor Fact Sheet
Share Registry Information
ASX Announcements
Filter by Year:
2024
2023
2022
2021
2020
2019
2018
2017
Older
20 Nov 2019
Results of Meeting
20 Nov 2019
Noxopharm 2019 AGM Corporate Presentations
12 Nov 2019
DARRT-1 Interim Data Presented To Conference
12 Nov 2019
LuPIN Data Being Presented To Conference
6 Nov 2019
Appointment of Chief Commercial Officer
30 Oct 2019
Noxopharm October 2019 Newsletter
30 Oct 2019
Appendix 4C - Quarterly Report for The Quarter Ending September 30, 2019
28 Oct 2019
Dr Graham Kelly to Assume CEO Role
25 Oct 2019
Appendix 3B
25 Oct 2019
Section 708 Certificate
Previous
1
2
3
4
5
6
7
8
9
10
11
Next
